News

Hims & Hers’ ugly split with Wegovy maker weighs on the firm’s future
Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a ...
Hims & Hers Health, Inc. (HIMS) Isn’t Regarded As A Great Actor By Doctors, Says Jim Cramer
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Hims & Hers Health, Inc.
Market Voices: Copper tariffs, mortgage volumes rise, Hims & Hers
Seeking Alpha's daily roundup of remarks and statements that could impact markets, sectors or individual stocks. Read more ...
InvestorsHub on MSN4d
Hims & Hers Shares Gain on Plans for Canadian Launch Featuring Generic Semaglutide
Hims & Hers Health (NYSE:HIMS) shares climbed 2% on Wednesday following the announcement of its planned market entry into ...
StockStory.org on MSN4d
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...
Explore more
Hims & Hers: My Main Concern Isn't Weight Loss, But Valuation (Rating Downgrade)
Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
Is Hims & Hers Stock in Trouble?
Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...
Hims & Hers Times Pivot to Canada With Generic Weight-Loss Drug After Wegovy Fallout -- Update
The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...